Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
—
-7x
20%
—
—
40%
—
5 Years
Score—
Net Growth-7x
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev Trend40%
Revenue Consistency—
Immunome Inc fundamental performance
Across Immunome Inc's full reported history, from 2020 to 2025, revenue grew from $ 0.00 to $ 6M and net income went from -$ 17M to -$ 212M. Revenue increased in 33% of the years measured; net income in 17%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 27.99 | — |
1 Year2025-08-12 | $ 9.91 | 182.44% |
5 Years2021-08-12 | $ 14.23 | 96.70% |
All Time2020-10-02 | $ 13.45 | 108.10% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-10-02 |
|---|---|---|---|---|
| Price | $ 27.99 | $ 9.91 | $ 14.23 | $ 13.45 |
| Return | — | 182.44% | 96.70% | 108.10% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 4M | -$ 224M | $ 582M |
| 2025 | $ 6M | -$ 212M | $ 653M |
| 2024 | $ 9M | -$ 292M | $ 217M |
| 2023 | $ 14M | -$ 106M | $ 138M |
| 2022 | $ 6M | -$ 36M | $ 20M |
| 2021 | $ 0.00 | -$ 24M | $ 49M |
| IPO2020 | $ 0.00 | -$ 17M | $ 39M |
Explore beyond IMNM
You're looking at Immunome Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
